| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
International staging system for multiple myeloma.
|
J Clin Oncol
|
2005
|
11.29
|
|
2
|
Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium.
|
Lancet Oncol
|
2006
|
4.13
|
|
3
|
Aspirin for everyone older than 50? For.
|
BMJ
|
2005
|
3.02
|
|
4
|
Effectiveness of an early supplementation scheme of high-dose vitamin A versus standard WHO protocol in Gambian mothers and infants: a randomised controlled trial.
|
Lancet
|
2007
|
3.01
|
|
5
|
Antimyeloma activity of heat shock protein-90 inhibition.
|
Blood
|
2005
|
2.24
|
|
6
|
Aspirin, salicylates, and cancer.
|
Lancet
|
2009
|
2.17
|
|
7
|
Guidelines for the diagnosis and management of multiple myeloma 2011.
|
Br J Haematol
|
2011
|
2.14
|
|
8
|
Molecular basis of the spectral expression of CIAS1 mutations associated with phagocytic cell-mediated autoinflammatory disorders CINCA/NOMID, MWS, and FCU.
|
Blood
|
2003
|
2.11
|
|
9
|
Balloon expandable stent implantation for native and recurrent coarctation of the aorta--prospective computed tomography assessment of stent integrity, aneurysm formation and stenosis relief.
|
Heart
|
2009
|
2.09
|
|
10
|
Early mortality after diagnosis of multiple myeloma: analysis of patients entered onto the United kingdom Medical Research Council trials between 1980 and 2002--Medical Research Council Adult Leukaemia Working Party.
|
J Clin Oncol
|
2005
|
1.97
|
|
11
|
Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation.
|
Hematol J
|
2003
|
1.81
|
|
12
|
Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN).
|
Blood
|
2011
|
1.75
|
|
13
|
Effects of bone-targeted agents on cancer progression and mortality.
|
J Natl Cancer Inst
|
2012
|
1.69
|
|
14
|
European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma.
|
Haematologica
|
2014
|
1.57
|
|
15
|
Tumor necrosis factor SNP haplotypes are associated with iron deficiency anemia in West African children.
|
Blood
|
2008
|
1.56
|
|
16
|
International Myeloma Working Group consensus statement for the management, treatment, and supportive care of patients with myeloma not eligible for standard autologous stem-cell transplantation.
|
J Clin Oncol
|
2014
|
1.52
|
|
17
|
Treatment of relapsed and refractory multiple myeloma in the era of novel agents.
|
Cancer Treat Rev
|
2010
|
1.48
|
|
18
|
Preclinical evaluation of the proteasome inhibitor bortezomib in cancer therapy.
|
Cancer Cell Int
|
2005
|
1.46
|
|
19
|
Genomic variation in myeloma: design, content, and initial application of the Bank On A Cure SNP Panel to detect associations with progression-free survival.
|
BMC Med
|
2008
|
1.40
|
|
20
|
Outcome of high-dose cytarabine-based induction therapy followed by hematopoietic stem cell transplantation in acute myeloid leukemia: influence of karyotype.
|
Leuk Lymphoma
|
2008
|
1.39
|
|
21
|
IMWG consensus on maintenance therapy in multiple myeloma.
|
Blood
|
2012
|
1.29
|
|
22
|
Essential role of proline isomerization in stefin B tetramer formation.
|
J Mol Biol
|
2006
|
1.23
|
|
23
|
International Myeloma Working Group recommendations for the treatment of multiple myeloma-related bone disease.
|
J Clin Oncol
|
2013
|
1.19
|
|
24
|
A national DNA bank in The Gambia, West Africa, and genomic research in developing countries.
|
Nat Genet
|
2004
|
1.13
|
|
25
|
Expression and activity of Toll-like receptors 1-9 in the human term placenta and changes associated with labor at term.
|
Biol Reprod
|
2008
|
1.13
|
|
26
|
Current multiple myeloma treatment strategies with novel agents: a European perspective.
|
Oncologist
|
2010
|
1.04
|
|
27
|
Dietary supplementation with lactobacilli and bifidobacteria is well tolerated and not associated with adverse events during late pregnancy and early infancy.
|
J Nutr
|
2010
|
1.04
|
|
28
|
More patent protection for medicines with a new purpose.
|
Nature
|
2010
|
1.02
|
|
29
|
Genes with a spike expression are clustered in chromosome (sub)bands and spike (sub)bands have a powerful prognostic value in patients with multiple myeloma.
|
Haematologica
|
2011
|
1.01
|
|
30
|
Birth season and environmental influences on blood leucocyte and lymphocyte subpopulations in rural Gambian infants.
|
BMC Immunol
|
2008
|
1.01
|
|
31
|
Atopic disease and childhood acute lymphoblastic leukemia.
|
Int J Cancer
|
2003
|
1.01
|
|
32
|
Early clinical experience with the new Amplatzer Ductal Occluder II for closure of the persistent arterial duct.
|
Catheter Cardiovasc Interv
|
2009
|
0.96
|
|
33
|
Monsanto Technology LLC v. Cargill: a matter of construction.
|
Nat Biotechnol
|
2008
|
0.95
|
|
34
|
Detection of intraepithelial and stromal Langerin and CCR5 positive cells in the human endometrium: potential targets for HIV infection.
|
PLoS One
|
2011
|
0.95
|
|
35
|
Phase I/II clinical study of Tosedostat, an inhibitor of aminopeptidases, in patients with acute myeloid leukemia and myelodysplasia.
|
J Clin Oncol
|
2010
|
0.93
|
|
36
|
Peripheral blood or bone marrow cells in reduced-intensity or myeloablative conditioning allogeneic HLA identical sibling donor transplantation for multiple myeloma.
|
Haematologica
|
2007
|
0.92
|
|
37
|
European Myeloma Network: the 3rd Trialist Forum Consensus Statement from the European experts meeting on multiple myeloma.
|
Leuk Lymphoma
|
2010
|
0.91
|
|
38
|
High-dose cyclophosphamide with stem cell rescue for severe rheumatoid arthritis: short-term efficacy correlates with reduction of macroscopic and histologic synovitis.
|
Arthritis Rheum
|
2002
|
0.90
|
|
39
|
Risk factors for acute shunt blockage in children after modified Blalock-Taussig shunt operations.
|
Heart Vessels
|
2010
|
0.90
|
|
40
|
A randomised trial of a remote home support programme for infants with major congenital heart disease.
|
Heart
|
2012
|
0.89
|
|
41
|
Efficacy and outcome of autologous transplantation in rare myelomas.
|
Haematologica
|
2010
|
0.89
|
|
42
|
CLLU1 expression has prognostic value in chronic lymphocytic leukemia after first-line therapy in younger patients and in those with mutated IGHV genes.
|
Haematologica
|
2012
|
0.87
|
|
43
|
Volunteer bias in recruitment, retention, and blood sample donation in a randomised controlled trial involving mothers and their children at six months and two years: a longitudinal analysis.
|
PLoS One
|
2013
|
0.86
|
|
44
|
Lenalidomide: a new therapy for multiple myeloma.
|
Cancer Treat Rev
|
2008
|
0.86
|
|
45
|
Multiple autophosphorylations significantly enhance the endoribonuclease activity of human inositol requiring enzyme 1α.
|
BMC Biochem
|
2014
|
0.85
|
|
46
|
Follicular lymphoma with a novel t(14;18) breakpoint involving the immunoglobulin heavy chain switch mu region indicates an origin from germinal center B cells.
|
Blood
|
2002
|
0.83
|
|
47
|
Using the Valeo dilatable stent in coarctation stenting for small children: expanding the inclusion criteria for coarctation stenting?
|
BMJ Case Rep
|
2013
|
0.83
|
|
48
|
Challenging the current approaches to multiple myeloma- and other cancer-related bone diseases: from bisphosphonates to targeted therapy.
|
Leuk Lymphoma
|
2012
|
0.82
|
|
49
|
Longer-term outcome of perventricular device closure of muscular ventricular septal defects in children.
|
Catheter Cardiovasc Interv
|
2015
|
0.82
|
|
50
|
Long-term effects of perinatal nutrition on T lymphocyte kinetics in young Gambian men.
|
Am J Clin Nutr
|
2007
|
0.81
|
|
51
|
Interactions of the auxilin-1 PTEN-like domain with model membranes result in nanoclustering of phosphatidyl inositol phosphates.
|
Biophys J
|
2013
|
0.81
|
|
52
|
Sympathetic ophthalmia secondary to cyclodiode laser in a 10-year-old boy.
|
J AAPOS
|
2009
|
0.81
|
|
53
|
Oestrogen receptor beta is present in both muscle fibres and endothelial cells within human skeletal muscle tissue.
|
Histochem Cell Biol
|
2005
|
0.80
|
|
54
|
Expression of prostaglandin E synthases in periodontitis immunolocalization and cellular regulation.
|
Am J Pathol
|
2011
|
0.80
|
|
55
|
Allele and haplotype frequency at human leucocyte antigen class I/II and immunomodulatory cytokine loci in patients with myelodysplasia and acute myeloid leukaemia: in search of an autoimmune aetiology.
|
Br J Haematol
|
2002
|
0.79
|
|
56
|
Thymic stromal lymphopoietin is present in human breast milk.
|
Pediatr Allergy Immunol
|
2010
|
0.79
|
|
57
|
Updates to the guidelines for the diagnosis and management of multiple myeloma.
|
Br J Haematol
|
2014
|
0.79
|
|
58
|
Chlamydia trachomatis antigens in enteroendocrine cells and macrophages of the small bowel in patients with severe irritable bowel syndrome.
|
BMC Gastroenterol
|
2010
|
0.78
|
|
59
|
Thymic function and T cell parameters in a natural human experimental model of seasonal infectious diseases and nutritional burden.
|
J Biomed Sci
|
2011
|
0.78
|
|
60
|
Tyrosine kinase inhibitor insensitivity of non-cycling CD34+ human acute myeloid leukaemia cells with FMS-like tyrosine kinase 3 mutations.
|
Br J Haematol
|
2011
|
0.77
|
|
61
|
Innate and adaptive immune pathways to tolerance.
|
Nestle Nutr Workshop Ser Pediatr Program
|
2009
|
0.77
|
|
62
|
Patent foramen ovale closure with the Gore septal occluder: initial UK experience.
|
Catheter Cardiovasc Interv
|
2013
|
0.77
|
|
63
|
Long-term clinical experience with Amplatzer Ductal Occluder II for closure of the persistent arterial duct in children.
|
Catheter Cardiovasc Interv
|
2014
|
0.76
|
|
64
|
Adjusting for patient crossover in clinical trials using external data: a case study of lenalidomide for advanced multiple myeloma.
|
Value Health
|
2011
|
0.76
|
|
65
|
What next for low dose aspirin?
|
J Epidemiol Community Health
|
2005
|
0.76
|
|
66
|
The impact of cell culture equipment on energy loss.
|
Lasers Med Sci
|
2013
|
0.75
|
|
67
|
Aspirin for all over 50 revisited.
|
Heart
|
2008
|
0.75
|
|
68
|
On the limitations of health impact assessment.
|
Public Health
|
2009
|
0.75
|
|
69
|
Could vitamin S (salicylate) protect against childhood cancer?
|
Med Hypotheses
|
2005
|
0.75
|
|
70
|
Aspirin resistance: What is the risk of cardiovascular morbidity?
|
BMJ
|
2008
|
0.75
|
|
71
|
Antibiotics and allergic disorders in childhood.
|
Open Nurs J
|
2008
|
0.75
|
|
72
|
Highlighting the importance of "popular epidemiology".
|
J Epidemiol Community Health
|
2005
|
0.75
|
|
73
|
My health: whose responsibility? Low-dose aspirin and older people.
|
Expert Rev Cardiovasc Ther
|
2006
|
0.75
|
|
74
|
Vascular hemostasis bandage compared to standard manual compression after cardiac catheterization in children.
|
Catheter Cardiovasc Interv
|
2011
|
0.75
|
|
75
|
Collection of peripheral blood stem cells in new patients with myeloma receiving minimal or no prior cytoreductive therapy.
|
Hematology
|
2007
|
0.75
|
|
76
|
Cancer-Selective Targeting of the NF-κB Survival Pathway with GADD45β/MKK7 Inhibitors.
|
Cancer Cell
|
2014
|
0.75
|
|
77
|
Retrieving a large embolised atrial septal occluder - hooked… and landed.
|
Kardiol Pol
|
2017
|
0.75
|
|
78
|
The public health potential of aspirin.
|
Pharmacol Toxicol
|
2002
|
0.75
|
|
79
|
2020 vision for Welsh 'public health'? Proposing 'public sector' footprints.
|
Perspect Public Health
|
2016
|
0.75
|
|
80
|
Super-resolution reconstruction based on incoherent optical aperture synthesis.
|
Opt Lett
|
2013
|
0.75
|
|
81
|
Designing and implementing healthy ageing policies.
|
Perspect Public Health
|
2012
|
0.75
|
|
82
|
'Healthy ageing' agenda.
|
Perspect Public Health
|
2012
|
0.75
|
|
83
|
High dose immunosuppressive therapy and stem cell transplantation in autoimmune and inflammatory diseases.
|
Int Immunopharmacol
|
2002
|
0.75
|
|
84
|
'Salicylic acid deficiency' has important public health implications.
|
Eur J Public Health
|
2003
|
0.75
|
|
85
|
Evolution of transcatheter closure of perimembranous ventricular septal defects in a single centre.
|
Catheter Cardiovasc Interv
|
2009
|
0.75
|
|
86
|
Life saving early and immediate aspirin: too little too late.
|
Postgrad Med J
|
2008
|
0.75
|
|
87
|
Reflective practice and self-awareness.
|
Perspect Public Health
|
2009
|
0.75
|